First PREMIER Bank Has $160,000 Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

First PREMIER Bank grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 7.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 274 shares of the healthcare conglomerate’s stock after buying an additional 18 shares during the period. First PREMIER Bank’s holdings in UnitedHealth Group were worth $160,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. Swedbank AB acquired a new stake in shares of UnitedHealth Group in the first quarter valued at about $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in UnitedHealth Group by 107.8% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock worth $1,141,113,000 after buying an additional 1,196,758 shares during the period. Lone Pine Capital LLC bought a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $480,903,000. Dimensional Fund Advisors LP increased its position in UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after acquiring an additional 880,183 shares during the period. Finally, Baillie Gifford & Co. boosted its holdings in UnitedHealth Group by 1,125.4% in the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock valued at $455,281,000 after purchasing an additional 821,050 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.7 %

NYSE:UNH traded up $3.96 during trading hours on Wednesday, hitting $585.54. 33,752 shares of the stock were exchanged, compared to its average volume of 3,929,426. The company’s 50 day moving average is $582.68 and its two-hundred day moving average is $529.13. The company has a market capitalization of $540.70 billion, a P/E ratio of 35.55, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company’s revenue was up 6.4% on a year-over-year basis. During the same period last year, the company earned $6.14 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Truist Financial increased their target price on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. UBS Group lifted their price objective on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a report on Thursday, July 18th. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and upped their target price for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. HSBC raised their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Finally, StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, September 25th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $614.17.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.